Chloe is the Junior QA/RA Consultant at LFH Regulatory. Building upon a foundation in academic neuroscience research, she completed a BSc in Neuroscience in 2016 from the University of Manchester before gaining vocational experience in pharmaceutical data intelligence. She later pursued an MSc in Clinical Neuroscience at UCL, focusing on utilising transcranial magnetic stimulation (TMS) combined with EEG as a biomarker for epilepsy.
Following her academic research, Chloe transitioned into clinical trials, acquiring hands-on experience in trial start-up and study management. In 2023, she expanded her expertise into regulatory affairs within the medical device industry, where she developed and maintained comprehensive technical file documentation, including clinical evaluations, risk management files, and post-market evaluations in compliance with UK and EU market requirements.
In the past year, Chloe further expanded her role to include Quality Management Systems (QMS) responsibilities by implementing and updating SOPs and supporting audits to streamline quality systems in accordance with ISO 13485 standards.
She is excited to leverage her scientific background and regulatory experience to support the delivery of safe and efficacious novel healthcare solutions and is committed to continuous learning and contributing positively to LFH Regulatory’s ongoing success.